ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P 500
5,618.26
-0.29%
US Tech 100
19,252.40
2.09%
Dow Jones
41,503.10
-0.25%
Brent Oil
73.575
1.65%
Bitcoin
62,450.65
1.26%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NYSE

  6. Taro Pharmaceutical Industries Ltd (TARO) Quote

Taro Pharmaceutical Industries Ltd

Taro Pharmaceutical Industries Ltd (TARO)

NYSE
42.97
0.00
(0.00%)
Closed September 18 4:00PM
Delayed by 15 minutes
42.97
0.00
( 0.00% )
Pre Market: 8:00PM
Delayed by 15 minutes

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

Key stats and details

Current Price
42.97
Bid
-
Ask
-
Volume
-
0.00 Day's Range 0.00
32.67 52 Week Range 45.76
Market Cap
1.615B
Previous Close
42.97
Open
-
Last Trade
Last Trade Time
-
Financial Volume
-
VWAP
-
Average Volume (3m)
-
Shares Outstanding
37,580,000
Dividend Yield
-
PE Ratio
29.98
Earnings Per Share (EPS)
1.43
Revenue
629.18M
Net Profit
53.87M

About Taro Pharmaceutical Industries Ltd

Taro Pharmaceutical Industries Ltd produces, researches, develops, and markets pharmaceutical products. Its primary focus includes semi-solids formulations, such as creams and ointments and other dosage forms such as liquids, capsules, and tablets. The company is engaged in the dermatological and to... Taro Pharmaceutical Industries Ltd produces, researches, develops, and markets pharmaceutical products. Its primary focus includes semi-solids formulations, such as creams and ointments and other dosage forms such as liquids, capsules, and tablets. The company is engaged in the dermatological and topical, cardiovascular, neuropsychiatric, and anti-inflammatory therapeutic categories. Geographically, it derives a majority of revenue from the United States and also has a presence in Canada, Israel, and Other Countries. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
www.taro.com
Headquarters
Haifa, North, Isr
Founded
-
Taro Pharmaceutical Industries Ltd is listed in the Pharmaceutical Preparations sector of the New York Stock Exchange with ticker TARO. The last closing price for Taro Pharmaceutical Indu... was $42.97. Over the last year, Taro Pharmaceutical Indu... shares have traded in a share price range of $ 32.67 to $ 45.76.

Taro Pharmaceutical Indu... currently has 37,580,000 shares outstanding. The market capitalization of Taro Pharmaceutical Indu... is $1.61 billion. Taro Pharmaceutical Indu... has a price to earnings ratio (PE ratio) of 29.98.

Ask ADVFN Intelligence (AI)

TARO Latest News

More News

Taro Shareholders Approve Merger with Sun Pharma

Taro Shareholders Approve Merger with Sun Pharma PR Newswire MUMBAI, India and NEW YORK, May 23, 2024 MUMBAI, India and NEW YORK, May 23, 2024 /PRNewswire/ -- Sun Pharmaceutical Industries...

May 23 2024
PR Newswire (US)

Form SC 13E3/A - Going private transaction by certain issuers: [Amend]

May 23 2024
Edgar (US Regulatory)

Taro Shareholders Approve Merger with Sun Pharma

Taro Shareholders Approve Merger with Sun Pharma Canada NewsWire MUMBAI, India and NEW YORK, May 23, 2024 MUMBAI, India and NEW YORK, May 23, 2024 /CNW/ -- Sun Pharmaceutical Industries Limited...

May 23 2024
PR Newswire (Canada)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

May 23 2024
Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

May 21 2024
Edgar (US Regulatory)

Taro Provides Results for Year Ended March 31, 2024

Taro Pharmaceutical Industries Ltd. (NYSE: TARO) (“Taro” or the “Company”) today provided unaudited financial results for the quarter and year ended March 31, 2024. Quarter ended March 31, 2024...

May 20 2024
Business Wire

Taro to Release Full Year Results on May 20, 2024

Taro Pharmaceutical Industries Ltd. (NYSE: TARO) announced today that it plans to release its financial results for year ended March 31, 2024, after the close of market on Monday, May 20, 2024...

May 15 2024
Business Wire

Form SC 13E3/A - Going private transaction by certain issuers: [Amend]

May 14 2024
Edgar (US Regulatory)

Form SC 13E3/A - Going private transaction by certain issuers: [Amend]

May 08 2024
Edgar (US Regulatory)
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10042.9742.9742.9700CS
40042.9742.9742.9700CS
120042.9742.9742.9700CS
260.952.2608281770642.0243.0341.891835542.57757531CS
524.9713.07894736843845.7632.673004741.0620797CS
156-21.49-33.338504498964.4665.2622.892755639.07113876CS
260-38.56-47.295474058681.5399.6922.893147056.05273113CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
DNMRDanimer Scientific Inc
$ 0.398
(15.97%)
7.03k
LGF.BLions Gate Entertainment Corp
$ 7.76
(10.54%)
424
MANUManchester United Plc
$ 17.75
(9.91%)
12
BKKTBakkt Holdings Inc
$ 11.94
(8.84%)
1
SMHISEACOR Marine Holdings Inc
$ 10.95
(8.52%)
8
EMPEntergy Mississippi LLC
$ 20.09
(-13.55%)
20
SCSSteelcase Inc
$ 12.99
(-7.94%)
3.5k
EGOEldorado Gold Corp Ltd
$ 16.23
(-4.87%)
500
ANVSAnnovis Bio Inc
$ 7.97
(-4.67%)
1
KUKEKuke Music Holding Limited
$ 0.69
(-4.18%)
95
NIONIO Inc
$ 5.29
(5.38%)
747.21k
PLTRPalantir Technologies Inc
$ 37.29
(2.50%)
237.23k
BABAAlibaba Group Holding Limited
$ 87.90
(4.12%)
235.93k
RIORio Tinto Plc
$ 65.62
(4.31%)
176.39k
XPEVXPeng Inc
$ 9.20
(6.48%)
174.69k

Discussion

View Full Feed
nicehit nicehit 3 minutes ago
Maybe after the next stock split you will get them at that price!
NVDA
CanItBThisEZ2Make CanItBThisEZ2Make 3 minutes ago
BEST SELLERS RANK (BSR) IS 689 44 Estimated Sold on Amazon Since JULY 1 - 3RD Quarter 2024
https://investorshub.advfn.com/uimage/uploads/2024/4/24/cnxttVOS_5G_GIF.gif
https://www.amazon.com/Vos-RDGL5GX55-B-01-VOS-5G-Dongle/dp/B0C66KHZLP

NOTE: In theory, when BSR Value De
SRMX
Welcome2Pinkyland Welcome2Pinkyland 4 minutes ago
Good morning Peepeeoil the super useless and extremely low level Ihub basher troll clown,
OBE OBE 8 minutes ago
Please explain how spinoff shares amount-to a R/S

I still own my 9M HCMC shares but now I have more shares (as an apparent "dividend") in a new entity listed on the NYSE, HCWC.
Does it say somewhere that the HCMC shares are going to be cancelled?
HCMC
TechandBio TechandBio 8 minutes ago
CRSP will climb tremendously over the years.
SMMT went from $1.00-30.00+ this year cancer drug superior to Mercks Keytruda
ICCM company being over looked that kills cancers by freezing them 97% non recurrence rate for breast cancer after 5 years and superior data to lung cancer safe c
CRSP ICCM SMMT
nowwhat2 nowwhat2 10 minutes ago
No you didn't........SHOW US where you said ANYTHING was coming......
My TA foretold Bitcoins' (and XRPs') drop from 57 down to 53
But whatever, carry on in your imaginary pumper world
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=175045665

https:
XRPUSD
Smitty5150 Smitty5150 10 minutes ago
I have reached out to Dave Innes several time in regards to this issue. Never heard back. So as always with everything NW, they leave the door open for speculation by others vs. the horses mouth. This is one of the biggest problems with this Management Team as it relates to being a shareholder, they
NWBO
koldkash koldkash 13 minutes ago
So what’s ur weeeeeeeeee of the day? Just curious
XCUR
Ms Labonte Ms Labonte 13 minutes ago
Fill em bid$$ junkie$$$ I want em all with leg$$ wide open$$$
RNAZ
Dallas-Cowboys Dallas-Cowboys 13 minutes ago
Nvidia, T-Mobile, Ericsson, and Nokia are teaming up to implement AI into networks. A new Nvidia buzz word “Nvidia AI Aerial” here is an excerpt from an article.

“T-Mobile CEO Mike Sievert said: “AI-RAN has tremendous potential to completely transform the future of mobile networks, b
NVDA
Ms Labonte Ms Labonte 13 minutes ago
When FDA new$$ hits it will be to late, need god$ gift from heaven all now$$$
RNAZ
starkd748 starkd748 14 minutes ago
Im a buyer if .0008s hold for another flip so far this trade has gone as exactly as I expected on the chart
DPLS
TechandBio TechandBio 17 minutes ago
$BTC Sound money digital gold should see 100-200k next year.
$SMMT went from $1.00-$25.00 better than Keytruda
ICCM icecure the founder of tencent owns over 50% of the shares kills many kinds of cancer by freezing it multiple studies some 5 years out undervalued.
https://www.pr
BTC ICCM SMMT
Smitty5150 Smitty5150 17 minutes ago
Also to your claim: You know nothing more than the next guy. Your right, in once sense. But in another would you argue that I am wrong in thinking the SP would fly with MHRA approval that coincided with NICE approval vs. just MHRA approval alone? I may not know "nothing more" but I do know what inv
NWBO
Ms Labonte Ms Labonte 18 minutes ago
I’m rolling $weet$$ got to $moke out em flipper$$$
MOKE WEET
jackson73 jackson73 19 minutes ago
TBIO 4.30 sweet
TBIO
jackson73 jackson73 20 minutes ago
TBIO 4.00+
TBIO
Bountiful_Harvest Bountiful_Harvest 21 minutes ago
Inflation 2.0

https://pbs.twimg.com/media/GX0n3SOakAIJnBB?format=jpg&name=4096x4096
AG
TechandBio TechandBio 21 minutes ago
non invasive platforms in medical field doing amazing things PLSE ICCM
ICCM PLSE
Princess17 Princess17 21 minutes ago
India took delivery of 47 mil oz
SLV
Smitty5150 Smitty5150 22 minutes ago
I have no idea who Fireman is, but my question still has not be answered with a definitive answer that is based on facts ( I dont like speculation) = Why hasn't NW started the evidence package for NICE? Why wasn't this being worked on well before the ASM? Linda Powers stated herself the work has be
ASM
Just the facts maam Just the facts maam 22 minutes ago
Sr Convertible Notes may start getting converted when ANIP trades at or above $96.34 for 20 consecutive days after September 30, 2024. The following is from ANIP's filing.

Generally. Subject to ?Section 5.01(C)(ii), a Note may be Converted only in the following circumstances:
ANIP
TrendTrade2016 TrendTrade2016 22 minutes ago
NOT MUCH FUN UNLESS YOU OWN IT...GREAT SHORT TRADE COMING UP
OMEX

Your Recent History

NYSE
TARO
Taro Pharmaceutical Indu...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved